Cathay Biotech Inc. (688065.SH) Proposes 2025 Employee Stock Ownership Plan

Cathay Biotech Inc. (688065.SH) has disclosed its 2025 Employee Stock Ownership Plan (Draft). The plan targets participants including company directors (excluding independent directors), senior management personnel, middle-level management staff, and technical/business backbone employees.

The employee stock ownership plan will initially involve no more than 155 participants (excluding reserved portions), of which 6 are directors and senior management personnel. The specific number of participants will be determined based on actual employee contributions.

The stock source for this employee ownership plan will be Cathay Biotech Inc.'s A-shares held in the company's share repurchase account. The plan intends to hold no more than 1.3 million target shares, representing approximately 0.18% of the company's total share capital at the time of the plan's announcement.

To meet the company's sustainable development needs and continuously attract and retain outstanding talent, the employee stock ownership plan proposes to reserve 150,000 shares as a reserved portion, accounting for 11.54% of the total shares in the employee stock ownership plan.

The purchase price for the target shares from the company's share repurchase account under this employee stock ownership plan is 25.53 yuan per share (including reserved portions).